Thyroid size change by CT monitoring after sorafenib or sunitinib treatment in patients with renal cell carcinoma: comparison with thyroid function.

MLA

Kitajima, Kazuhiro, et al. “Thyroid Size Change by CT Monitoring after Sorafenib or Sunitinib Treatment in Patients with Renal Cell Carcinoma: Comparison with Thyroid Function.” European Journal of Radiology, vol. 81, no. 9, Sept. 2012, pp. 2060–65. EBSCOhost, https://doi.org/10.1016/j.ejrad.2011.06.035.

APA

Kitajima, K., Takahashi, S., Maeda, T., Yoshikawa, T., Ohno, Y., Fujii, M., Miyake, H., Fujisawa, M., & Sugimura, K. (2012). Thyroid size change by CT monitoring after sorafenib or sunitinib treatment in patients with renal cell carcinoma: comparison with thyroid function. European Journal of Radiology, 81(9), 2060–2065. https://doi.org/10.1016/j.ejrad.2011.06.035

Chicago

Kitajima, Kazuhiro, Satoru Takahashi, Tetsuo Maeda, Takeshi Yoshikawa, Yoshiharu Ohno, Masahiko Fujii, Hideaki Miyake, Masato Fujisawa, and Kazuro Sugimura. 2012. “Thyroid Size Change by CT Monitoring after Sorafenib or Sunitinib Treatment in Patients with Renal Cell Carcinoma: Comparison with Thyroid Function.” European Journal of Radiology 81 (9): 2060–65. doi:10.1016/j.ejrad.2011.06.035.